Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy

Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy

US Patent 12371747 · Granted Jul 29, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

DCN-1 modulating compounds and methods of use thereof2025
Modulators of DCN-1 and methods of use thereof2025
Methods of using a bispecific antigen-binding construct targeting HER2 for the t2025
Nucleic acid molecules and uses thereof for non-viral gene therapy2025
Optimized factor IX gene2025
Factor VIII chimeric and hybrid polypeptides, and methods of use thereof2025
Factor VIII chimeric and hybrid polypeptides, and methods of use thereof2025
Methods for the purification of viral vectors2024
Nucleic acid molecules and uses thereof2024
Methods of reducing side effects of anti-CD30 antibody drug conjugate therapy2023
Optimized factor VIII genes2023
Assays to monitor bleeding disorders2023